June 10, 2009 – Hawaii-based Kai Sensors announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Kai Sensors Non- Contact Respiratory Rate Spot Check, also called the Kai RSpot. The 510(k) clearance allows Kai Sensors to market the Kai RSpot to physicians, hospitals, and clinics.
The Kai RSpot is a device that offers a practical and effective approach of measuring respiratory rate in hospital and clinical settings. The device is easy to use and works wirelessly, with no contact or attachment to the patient.
Due to difficulties with current approaches of measuring respiratory rate, this important vital sign is often measured infrequently, inaccurately, inconsistently, or not at all. The clinically tested Kai RSpot provides a solution that addresses many of the shortcomings of existing technologies, and will enable doctors and health care professionals to measure a patient’s respiration with greater ease and with increased regularity...
...
About Kai Sensors, Inc.
Headquartered in Honolulu, Hawaii, Kai Sensors develops products designed to measure and monitor vital signs wirelessly, with no contact to the patient, and from a distance. Kai Sensors’ products are designed for use in the medical, homeland security, and other markets... [PDF] Kai Sensors' Press Release -
Blog Archive
-
▼
2009
(26)
-
▼
July
(10)
- Weinmann : MEDUMAT Transport offers multi-faceted ...
- CanBas and The Takeda Oncology Company (Millennium...
- Allos Therapeutics Completes Enrollment in Randomi...
- Endocyte : data on EC145 at the IASLC 13th World C...
- Boehringer Ingelheim and DxS : agreement for a com...
- Kai Sensors : FDA Clearance for its Wireless, Non-...
- Osmetech : FDA clears its Cystic Fibrosis Genotypi...
- Alnara Pharmaceuticals Licenses Worldwide Rights t...
- YM BioSciences : DAIICHI-SANKYO ENROLLS FIRST PATI...
- bitop AG and Activaero : collaboration on clinical...
-
▼
July
(10)